insights_auto
Why is MRNA up 2.37%?
Dive Deeperchevron_right
MRNA:NASDAQ
Moderna Inc
$191.91
arrow_upward
+2.37%(+4.45) 1D
Oct 7, 1:55:41 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MRNA...
Open
$183.64
High
$193.99
Low
$182.50
Mkt. cap
76.53B
Avg. vol.
17.52M
Volume
8.08M
52-wk high
$212.19
52-wk low
$22.29
EPS
-$7.98
Beta
1.09
Shares outstanding
399.24M
No. of employees
5K
Open
$183.64
High
$193.99
Low
$182.50
Mkt. cap
76.53B
Avg. vol.
17.52M
Volume
8.08M
52-wk high
$212.19
52-wk low
$22.29
EPS
-$7.98
Beta
1.09
Shares outstanding
399.24M
No. of employees
5K
News stories
From web sources and news partners
MarketBeat
·
9 minutes ago
Moderna, Inc. $MRNA Shares Sold by Lake Hills Wealth Management LLC
Benzinga
·
15 minutes ago
Tempus AI Doubles Down On Moderna and Merck Cancer Vaccine Infrastructure
Traders Union
·
3 hours ago
Moderna stock resistance test at $197.74: Key levels to watch
Investing.com UK
·
5 hours ago
Tempus expands collaboration with Merck and Moderna on therapy By Investing.com
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc